Your browser doesn't support javascript.
loading
Performance evaluation of the Aptima HIV-1 RNA Quant assay on the Panther system using the standard and dilution protocols.
Rossetti, Rebecca; Smith, Tara; Luo, Wei; Taussig, Jennifer; Valentine-Graves, Mariah; Sullivan, Patrick; Ingersoll, Jessica M; Kraft, Colleen S; Ethridge, Steve; Wesolowski, Laura; Delaney, Kevin P; Owen, S Michele; Johnson, Jeffrey A; Masciotra, Silvina.
Afiliação
  • Rossetti R; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, United States. Electronic address: nvp4@cdc.gov.
  • Smith T; Oak Ridge Institute for Science and Education Assigned to Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, United States.
  • Luo W; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, United States.
  • Taussig J; Department of Epidemiology, Rollins School of Public Health, Emory University, United States.
  • Valentine-Graves M; Department of Epidemiology, Rollins School of Public Health, Emory University, United States.
  • Sullivan P; Department of Epidemiology, Rollins School of Public Health, Emory University, United States.
  • Ingersoll JM; Department of Pathology and Laboratory Medicine, Emory University, United States.
  • Kraft CS; Department of Pathology and Laboratory Medicine, Emory University, United States.
  • Ethridge S; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, United States.
  • Wesolowski L; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, United States.
  • Delaney KP; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, United States.
  • Owen SM; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, United States.
  • Johnson JA; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, United States.
  • Masciotra S; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, United States.
J Clin Virol ; 129: 104479, 2020 08.
Article em En | MEDLINE | ID: mdl-32531665

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 Idioma: En Ano de publicação: 2020 Tipo de documento: Article